‘Not unnoticed’: Sunak issues letter of support to community pharmacy

Prime Minister Rishi Sunak has written to the Sigma Pharmaceuticals conference to express his “personal gratitude” to the sector.

“Your incredible work does not go unnoticed”, the Prime Minister said

Prime Minister Rishi Sunak has expressed his “personal gratitude” to the community pharmacy sector, in a letter of “encouragement and support” addressed to Sigma Pharmaceutical’s 2023 UK community pharmacy conference.

Lord Dolar Popat, who opened the Sigma event yesterday (November 5), read out the letter to delegates – stressing that the Prime Minister is the “son of a pharmacist”.

Read more: In full: Rishi Sunak's letter to the sector

Mr Sunak wrote that the government “very much appreciates” the community pharmacy sector’s “hard work”.

He said that community pharmacies play an “important role in maintaining and looking after local communities”, adding that this “incredible work” was not “unnoticed”.

He ended his letter by expressing his hope that the delegates felt “recognised” for their work.

Pharmacy First will prove “value and trust”

Mr Sunak’s letter also said that the government wants to “enable” the sector to “do more to support the NHS”.

The Prime Minister said that the upcoming Pharmacy First service, announced in May, would be “an important addition” to the work of pharmacies, with pharmacists providing initial assessments of patients and “some options for treatment” without a patient requiring a GP appointment.

Read more: Pharmacy First negotiations ‘concluded’, CPE chief announces

He added that additional services provided by pharmacists under the deal would prove “how valuable and trusted” community pharmacy is within communities.

It comes as C+D today (November 6) reported that the negotiations for the Pharmacy First deal had been concluded with the details to be announced “very shortly”, according to Community Pharmacy England (CPE) chief executive Janet Morrison.

Sign in or register for free

James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

Contractors to receive April and May SAF uplift ‘sooner’

 
• By 
 • comment

Contractors will reap the benefits of the increased single activity fee (SAF) without having to wait 60 days from the end of April and May, Community Pharmacy England (CPE) has announced.

What pressures do new independent prescribers face?

 
• By 
 • comment

As all newly qualified pharmacists become independent prescribers from 2026, a pharmacy lecturer shares some of the concerns her students have shared as they complete their studies…

Pfizer scraps second attempt at weight loss pill

 
• By 
 • comment

Pfizer has announced it will “discontinue” the development of a weight loss pill amid “potential drug-induced liver injury”, less than two years after it decided “not [to] advance” a previous version.

More from Politics

‘Last resort’: Government faces judicial review over NICs hike

 
• By 
 • comment

A representative body has taken legal action against the government following MPs’ rejection of a bill amendment that would have exempted pharmacies from next week’s employer NICs hike.

Kinnock: Collective action is ‘premature, unnecessary and detrimental’

 
• By 
 • comment

The pharmacy minister has urged the NPA to “reconsider” its call for member pharmacies to take collective action from next week, arguing that it will be “detrimental to patients”.